Drexel Hamilton Lowers Price Target on MicroStrategy (MSTR), Stock still a Sell
Tweet
Share
E-mailGet Alerts MSTR Hot Sheet
Price: $111.33 +6.79%
Rating Summary:
22 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
22 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
Drexel Hamilton maintained their Sell rating on MicroStrategy (NASDAQ: MSTR) and lowered their price target to $80.00 (from $90.00)
Analyst James Gilman said "We have updated our financial model following the release of MicroStrategy’s Form 10-Q for 2Q12. We change our forward estimates based on disclosures contained within the form. We think the top-line miss that occurred in 2Q occurred due to a smaller sales force. During the quarter the company shed 28 sales and marketing heads and has shed a total of 88 sales and marketing heads since the beginning of the year. As we have previously pointed out, revenue scales with headcount."
For an analyst ratings summary and ratings history on MicroStrategy click here. For more ratings news on MicroStrategy click here.
Shares of MicroStrategy closed at $122.33 yesterday.
Analyst James Gilman said "We have updated our financial model following the release of MicroStrategy’s Form 10-Q for 2Q12. We change our forward estimates based on disclosures contained within the form. We think the top-line miss that occurred in 2Q occurred due to a smaller sales force. During the quarter the company shed 28 sales and marketing heads and has shed a total of 88 sales and marketing heads since the beginning of the year. As we have previously pointed out, revenue scales with headcount."
For an analyst ratings summary and ratings history on MicroStrategy click here. For more ratings news on MicroStrategy click here.
Shares of MicroStrategy closed at $122.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- Deutsche Bank Starts Ardagh Metal Packaging S.A. (AMBP) at Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
